Ensysce Biosciences ENSC Cash Flow Statement (2018-2025)

NASDAQ ENSC
$0.52 +0.02 (+4.29%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Ensysce Biosciences Quarterly Cash Flow Statement

Periods 32 quarters
Latest Dec 2025

Ensysce Biosciences cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 32 quarters of results from Mar 2018 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income
-0.91M-0.96M-17.20M-10.04M-0.95M-7.92M-9.86M-5.48M-2.19M-2.24M-2.69M-3.50M-3.12M-1.97M0.66M-3.56M-1.95M-1.73M-3.73M
Depreciation and DepletionDep. & Depletion
51.0050.0050.00
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.17M0.03M0.30M
Depreciation & Amortization (CF)Dep. & Amort.
51.0050.0050.00
Share-based CompensationStock Comp.
0.04M0.04M0.02M0.02M1.74M-1.003.000.12M0.08M0.06M0.63M0.03M0.03M0.02M0.03M0.02M0.21M-0.08M
Deferred Taxes
-0.06M
Gains from Sales and DivestituresGains Divest
0.00M
Gains from Investment SecuritiesGains Investment
-0.04M0.71M
Other non-cash itemsOther Non-Cash
0.17M0.35M10.49M4.06M-2.77M1.04M5.01M2.11M-0.15M0.43M0.01M0.01M0.01M-0.01M0.01M-853.00998.0035.00
Change in Working Capital
Change in Account PayablesChange Payables
-0.09M0.44M-1.60M-0.17M0.66M2.09M-1.76M1.66M-1.35M-0.32M-0.36M0.79M-1.30M-0.50M1.74M-0.52M-0.74M0.43M-0.58M
Change in Accured ExpensesChange Accured Exp.
0.17M0.14M2.19M-0.32M0.09M0.46M0.42M0.05M-0.05M-0.99M-0.03M-0.22M-0.13M-0.04M0.04M0.18M0.39M-0.04M0.36M
Change in TaxesChange Taxes
Change in Other Operating AssetsOther Assets Change
-0.05M0.02M0.80M1.29M-0.21M0.21M-0.77M-1.04M-0.23M-0.41M-0.77M-0.17M0.09M-0.15M3.48M-3.39M-0.54M1.62M-1.98M1.20M
Other Working Capital ChangesOther WC Changes
0.05M-0.02M-0.80M-1.29M0.21M-0.21M0.77M1.04M0.23M0.41M0.77M0.17M-0.09M0.15M-3.48M3.39M0.54M-1.62M1.98M-1.20M
Cash from OperationsCash from Ops.
-0.52M-0.13M-3.82M-3.77M-3.44M-4.44M-6.71M-3.30M-3.61M-3.11M-2.26M-1.80M-3.41M-2.31M-1.02M-0.76M-1.71M-2.71M-1.87M
Investing Activities
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M
Change in Property, Plant and EquipmentChange in PP&E
0.00M
Purchase of InvestmentsInvestments Purchased
0.06M
Sale and Maturity of InvestmentsInvestments Sold
Cash from Investing ActivitiesCash from Investing
-0.06M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.35M0.05M4.50M9.48M
Long-Term Debt RepaymentsLT Debt Repayment
1.14M0.42M0.58M0.49M
Non-Current Debt
0.35M0.05M4.50M9.48M-1.14M-0.42M-0.58M-0.49M
Short-Term Debt repaymentsST Debt Repayment
0.29M0.39M0.05M0.15M0.20M0.10M0.14M0.15M0.05M0.07M0.10M0.05M0.02M0.04M0.11M
Current Debt
-0.29M-0.39M-0.05M-0.15M-0.20M-0.10M-0.14M-0.15M-0.05M-0.07M-0.10M-0.05M-0.02M-0.04M-0.11M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.35M0.05M4.50M9.19M-0.39M-0.05M-1.30M-0.62M-0.58M-0.10M-0.14M-0.64M-0.05M-0.07M-0.10M-0.05M-0.02M-0.04M-0.11M
Change in Capital Stock
Common Stock IssuedStock Issued
0.26M7.80M-1.18M2.69M6.36M2.08M1.67M0.36M1.45M0.04M1.50M
Net Shares Issued and RepurchasedNet Shares Issued
0.26M7.80M-1.18M2.69M6.36M2.08M1.67M0.36M1.45M0.04M1.50M
Net Equity Issued and RepurchasedNet Equity Issued
0.26M7.80M-1.18M2.69M6.36M2.08M1.67M0.36M1.45M0.04M1.50M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.61M7.85M2.66M9.19M-0.39M-0.27M7.48M1.94M1.87M5.52M-0.10M1.46M5.69M-0.05M4.13M0.11M1.26M1.87M1.45M
Additional items
Change in Cash
0.10M7.72M-1.17M5.42M-3.82M-4.71M0.77M-1.36M-1.73M2.41M-2.37M-0.34M2.28M-2.36M3.11M-0.65M-0.45M-0.84M-0.54M
Ending Cash Balance
0.29M8.01M6.85M12.26M8.44M3.73M4.50M3.15M1.42M3.83M1.46M1.12M3.40M1.04M4.15M3.50M3.05M2.21M1.67M4.31M
Free Cash FlowFCF
-0.52M-0.13M-3.82M-3.77M-3.44M-4.44M-6.71M-3.30M-3.61M-3.11M-2.26M-1.80M-3.41M-2.31M-1.02M-0.76M-1.71M-2.71M-1.87M
Net Cash FlowNCF
0.03M7.72M-1.17M5.42M-3.82M-4.71M0.77M-1.36M-1.73M2.41M-2.37M-0.34M2.28M-2.36M3.11M-0.65M-0.45M-0.84M-0.41M
Income Taxes PaidTaxes Paid
0.00M

Ensysce Biosciences Cash Flow Statement API

Pull Ensysce Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ENSC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY